Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2574707013 | Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2578104016 | Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2580414010 | Amphotericin (colloidal dispersion) 5mg/mL suspension for injection 20mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2580415011 | Amphotericin (lipid complex) 5mg/mL suspension for injection 20mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2580416012 | Amphotericin (liposomal) 5mg/mL suspension for injection 20mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 4911151000005115 | amphotericin 5 mg/ml, lipidformulering, suspension til injektionsvæske, hætteglas a 20 ml | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Danish module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| amphotericin 5 mg/ml, lipidformulering, suspension til injektionsvæske, hætteglas a 20 ml | Is a | amphotericin B-liposom | false | Inferred relationship | Some | ||
| amphotericin 5 mg/ml, lipidformulering, suspension til injektionsvæske, hætteglas a 20 ml | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Amphotericin B liposome (substance) | false | Inferred relationship | Some | ||
| amphotericin 5 mg/ml, lipidformulering, suspension til injektionsvæske, hætteglas a 20 ml | Has manufactured dose form | injektionsvæske | false | Inferred relationship | Some | ||
| amphotericin 5 mg/ml, lipidformulering, suspension til injektionsvæske, hætteglas a 20 ml | Is a | amphotericin til parenteral anvendelse | false | Inferred relationship | Some | ||
| amphotericin 5 mg/ml, lipidformulering, suspension til injektionsvæske, hætteglas a 20 ml | Has manufactured dose form | Suspension for injection | false | Inferred relationship | Some | ||
| amphotericin 5 mg/ml, lipidformulering, suspension til injektionsvæske, hætteglas a 20 ml | Is a | Product containing amphotericin B liposome in parenteral dosage form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR